Skip to content

Clinical trials

Phase 2/3 Leukemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 2/3 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20101
20172
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Jude Children's Research Hospital2
Amgen1
Ann & Robert H Lurie Children's Hospital of Chicago1
Chimeric Therapies1
Jazz Pharmaceuticals1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
Roswell Park Cancer Institute1
Taiho Oncology, Inc.1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia11
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes5
Anemia, Refractory, with Excess of Blasts4
Lymphoma4
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Chronic-Phase3
Leukemia, Myelomonocytic, Chronic3
Neoplasms3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.